T. Rowe Price Associates »

Tg Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 81k 17.09
2023-09-30 $446k 53k 8.36
2023-06-30 $7.4M 298k 24.84
2023-03-31 $1.1M 75k 15.05
2022-12-31 $1.1M 93k 11.83
2022-03-31 $5.5M 581k 9.51
2021-12-31 $11M 581k 19.00
2021-09-30 $47M 1.4M 33.28
2021-06-30 $73M 1.9M 38.79
2021-03-31 $78M 1.6M 48.20
2020-12-31 $73M 1.4M 52.02
2020-09-30 $1.4M 51k 26.76
2018-09-30 $220k 39k 5.60
2018-06-30 $512k 39k 13.15
2018-03-31 $564k 40k 14.19
2017-12-31 $432k 53k 8.19
2017-06-30 $148k 15k 10.04
2017-03-31 $171k 15k 11.63
2016-12-31 $68k 15k 4.63
2016-09-30 $114k 15k 7.76